Seelaus Asset Management LLC Cuts Stake in SPDR S&P Biotech ETF (NYSEARCA:XBI)

Seelaus Asset Management LLC lowered its position in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 27.1% in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 3,663 shares of the exchange traded fund’s stock after selling 1,359 shares during the quarter. Seelaus Asset Management LLC’s holdings in SPDR S&P Biotech ETF were worth $330,000 as of its most recent filing with the SEC.

Other large investors also recently bought and sold shares of the company. Golden State Wealth Management LLC purchased a new position in shares of SPDR S&P Biotech ETF in the 4th quarter valued at about $29,000. Avior Wealth Management LLC increased its holdings in shares of SPDR S&P Biotech ETF by 393.6% in the 4th quarter. Avior Wealth Management LLC now owns 385 shares of the exchange traded fund’s stock valued at $35,000 after purchasing an additional 307 shares in the last quarter. Tidemark LLC increased its holdings in shares of SPDR S&P Biotech ETF by 101.5% in the 3rd quarter. Tidemark LLC now owns 395 shares of the exchange traded fund’s stock valued at $39,000 after purchasing an additional 199 shares in the last quarter. Quintet Private Bank Europe S.A. purchased a new position in shares of SPDR S&P Biotech ETF in the 3rd quarter valued at about $40,000. Finally, ORG Wealth Partners LLC purchased a new position in shares of SPDR S&P Biotech ETF in the 3rd quarter valued at about $44,000.

SPDR S&P Biotech ETF Stock Down 2.3 %

Shares of XBI opened at $91.24 on Friday. The company has a market capitalization of $6.95 billion, a PE ratio of 11.47 and a beta of 1.11. SPDR S&P Biotech ETF has a 52-week low of $81.14 and a 52-week high of $105.47. The company has a 50-day simple moving average of $92.58 and a 200-day simple moving average of $96.48.

SPDR S&P Biotech ETF Company Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.